A importância da atenção farmacêutica aos pacientes portadores de xeroderma pigmentoso 1

Abstract

Xeroderma pigmentosum is a rare, genetic, autosomal recessive and is more common in consanguineous marriages, marked by sensitivity to sunlight. It is a disease caused due to mutations in DNA genes, which hinders the production of proteins that are responsible for correct the damage caused by ultraviolet light in the DNA. These patients use a variety of medications due to diseases associated with Xeroderma pigmentosum is relevant monitoring pharmacist and pharmaceutical care seeking the benefits that can be observed by increasing the survival of these patients. The general objective of this study is to investigate how treatment is performed of patients with Xeroderma pigmentosum and the use of medications and any continuous, due to diseases associated with the purpose of achieving concrete results that improve the quality of life of patients. The present study is a descriptive, exploratory, quantitative approach and analysis based on simple statistics. The same was done with five patients with Xeroderma pigmentosum. Given the survey results, it is worth noting the importance of pharmaceutical care to patients with Xeroderma pigmentosum, for through this monitoring the pharmacist will be able to clarify questions about the drugs. Thus by monitoring the pharmacist assists the patient directly, evaluating and directing the same in relation to pharmacotherapy prescribed by the doctor, through the analysis of their needs related to drugs, also detecting drug-related problems.